Insider · CIK 0001239463
Michael D Webb
Files at ENVB (Enveric Biosciences, Inc.). First filing -, latest -.
In brief
Michael D Webb files SEC Form 4 as director at ENVB (Enveric Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael D Webb has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +18,518 | $0.00 | $0 | 26,416 | Jun 3, 2026 |
| Dec 23, 2025 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +7,633 | $0.00 | $0 | 7,898 | Dec 30, 2025 |
| Oct 9, 2024 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +47,733 | $0.00 | $0 | 47,733 | Oct 11, 2024 |
Questions about Michael D Webb
Answered from the filings on this page, as of the latest one.
Is Michael D Webb buying or selling?
Michael D Webb has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael D Webb's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael D Webb has 0.
Where does Michael D Webb file Form 4?
Michael D Webb has filed Form 4 at ENVB (Enveric Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.